Cited 0 times in
Post hoc analysis of pembrolizumab efficacy in potentially platinum ineligible patients with urothelial carcinoma enrolled in KEYNOTE-052 and LEAP-011
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.